|
?:authorAffiliation
|
-
[\'Department of Microbiology and Immunology, University of North Carolina School of Medicine, Chapel Hill NC 27599, USA prem@med.unc.edu aravinda_desilva@med.unc.edu.\', \'Department of Microbiology and Immunology, University of North Carolina School of Medicine, Chapel Hill NC 27599, USA.\', \'Department of Epidemiology, UNC Chapel Hill School of Public Health, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.\', \'Departments of Medicine, University of North Carolina School of Medicine, Chapel Hill NC 27599, USA.\', \'Immunology/Histocompatibility and Immunogenetics Laboratories, University of North Carolina School of Medicine, Chapel Hill NC 27599, USA.\', \'Department of Pathology & Laboratory Medicine, University of North Carolina School of Medicine, Chapel Hill NC 27599, USA.\', \'Hope Clinic of the Emory Vaccine Center, Division of Infectious Diseases, Department of Medicine, School of Medicine, Emory University, Decatur, Georgia, USA.\', \'Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology (LJI), La Jolla, CA 92037, USA.\', \'Department of Medicine, Division of Infectious Diseases and Global Public Health, University of California, San Diego (UCSD), La Jolla, CA 92037, USA.\']
|
![[This page as RDF]](https://research.tib.eu/covid-19/static/rdf-icon.gif){kind=icon}